(MP4 3429 kb) Studies investigating the mechanism of action of GLP-1RA therapy for causing weight loss provide evidence that GLP-1RA treatment is associated with reductions in appetite and hunger, lower preference for energy-dense foods, alteration in food reward pathways, decrease in food cravings, and improvement in eating control (Table 2) [25, 26, 33, 34]
But when done correctly, sublingual administration offers a needle-free alternative that many people prefer, and the results can be genuinely comparable when absorption is optimized
Clinical trials hold each dose for four weeks before escalation, and this is not arbitrary
Sodum, N., Mattila, O., Sharma, R., Kamakura, R., Lehto, V
Carey RM, Wright JT Jr, Taler SJ, Whelton PK